TY - JOUR
T1 - 2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 1
T2 - Discovery of CB2 receptor selective compounds
AU - Kai, Hiroyuki
AU - Morioka, Yasuhide
AU - Murashi, Takami
AU - Morita, Koichi
AU - Shinonome, Satomi
AU - Nakazato, Hitoshi
AU - Kawamoto, Keiko
AU - Hanasaki, Kohji
AU - Takahashi, Fumiyo
AU - Mihara, Shin ichi
AU - Arai, Tohko
AU - Abe, Kohji
AU - Okabe, Hiroshi
AU - Baba, Takahiko
AU - Yoshikawa, Takayoshi
AU - Takenaka, Hideyuki
PY - 2007/7/15
Y1 - 2007/7/15
N2 - 2-Arylimino-5,6-dihydro-4H-1,3-thiazines have been identified as a novel class of cannabinoid agonists. A lead structure with moderate activity was discovered through a high throughput screening assay. Structure-activity relationships led to the discovery of potent agonists of CB2 receptor. The most potent compound 13 displays Ki values of >5000 and 9 nM to CB1 and CB2 receptors, respectively.
AB - 2-Arylimino-5,6-dihydro-4H-1,3-thiazines have been identified as a novel class of cannabinoid agonists. A lead structure with moderate activity was discovered through a high throughput screening assay. Structure-activity relationships led to the discovery of potent agonists of CB2 receptor. The most potent compound 13 displays Ki values of >5000 and 9 nM to CB1 and CB2 receptors, respectively.
KW - 1,3-Thiazine
KW - CB
KW - CB
KW - CB receptor selective
KW - Cannabinoid receptor agonist
KW - Pain
KW - Structure-activity relationship
UR - http://www.scopus.com/inward/record.url?scp=34250322008&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34250322008&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2007.04.093
DO - 10.1016/j.bmcl.2007.04.093
M3 - Article
C2 - 17521907
AN - SCOPUS:34250322008
SN - 0960-894X
VL - 17
SP - 4030
EP - 4034
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 14
ER -